| Spontaneous pneumomediastinum secondary to refractory dermatomyositis successfully treated with rituximab. | |
| | |
MedLine Citation:
|
PMID: 20195881 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Spontaneous pneumomediastinum has been described in patients with dermatomyositis (DM) and polymyositis (Korkmaz et al., Rheumatology 40:476-478, 2001; Maruoka et al., Mod Rheumatol 16:55-57, 2006; Kono et al., Ann Rheum Dis 59:372-376, 2000; Neves et al., Clin Rheumatol 26:105-107, 2007). Literature reviews suggest that this complication has a mortality of between 27% and 41% ( Kono et al., Ann Rheum Dis 59:372-376, 2000; Neves et al., Clin Rheumatol 26:105-107, 2007; Goff et al., Arthritis Rheum 61:108-118, 2009). This is the first report of rituximab being used successfully as part of the treatment for DM complicated by pneumomediastinum. |
| | |
Authors:
|
Martin A Lee; David G Hutchinson |
Publication Detail:
|
Type: Case Reports; Journal Article Date: 2010-03-01 |
Journal Detail:
|
Title: Clinical rheumatology Volume: 29 ISSN: 1434-9949 ISO Abbreviation: Clin. Rheumatol. Publication Date: 2010 Aug |
Date Detail:
|
Created Date: 2010-07-02 Completed Date: 2010-10-21 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8211469 Medline TA: Clin Rheumatol Country: Germany |
Other Details:
|
Languages: eng Pagination: 945-6 Citation Subset: IM |
Affiliation:
|
Rheumatology Department, Royal Devon & Exeter Hospital, Exeter, Devon, UK. martinlee@doctors.org.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antibodies, Monoclonal
/
therapeutic use* Antirheumatic Agents / therapeutic use* Dermatomyositis / complications* Female Humans Mediastinal Emphysema / drug therapy*, etiology* Treatment Outcome Young Adult |
| Chemical | |
Reg. No./Substance:
|
0/Antibodies, Monoclonal; 0/Antirheumatic Agents; 0/rituximab |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Juvenile idiopathic arthritis among Nigerians: a case study.
Next Document: Determination of teicoplanin trough concentration target and appropriate total dose during the first...